About SPI Pharma
SPI Pharma is a company based in Wilmington (United States) founded in 2000. The company has 22 employees as of April 05, 2024. SPI Pharma offers products and services including Pharmaburst 500, Mannogem Mannitol, Pharmasperse, and UltraBurst. SPI Pharma operates in a competitive market with competitors including Colorcon, Pfanstiehl, Scope Ingredients, Crest Cellulose and DFE Pharma, among others.
- Headquarter Wilmington, United States
- Employees 22 as on 05 Apr, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Spi Specialties Pharma Private Limited
- Date of Incorporation 05 Dec, 2013
- Jurisdiction Bengaluru, Karnataka, India
-
Annual Revenue
$1.11 M (USD)22.01as on Mar 31, 2022
-
Net Profit
$126.34 K (USD)27.36as on Mar 31, 2022
-
EBITDA
$207.01 K (USD)43.26as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
22
as on Apr 05, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SPI Pharma
SPI Pharma offers a comprehensive portfolio of products and services, including Pharmaburst 500, Mannogem Mannitol, Pharmasperse, and UltraBurst.
Enables rapid disintegration for orally disintegrating tablets.
Provides mannitol for efficient tablet formulation and stability.
Offers powder platform for sachets with patient-friendly benefits.
Delivers fast disintegration for tablets with high hardness.
People of SPI Pharma
Unlock access to complete
Funding Insights of SPI Pharma
Detailed funding history for SPI Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SPI Pharma
Investment portfolio details for SPI Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - SPI Pharma
Detailed financials for SPI Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Spi Pharma Comparisons
Peer comparison for SPI Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SPI Pharma
SPI Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Colorcon, Pfanstiehl, Scope Ingredients, Crest Cellulose and DFE Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of specialty excipients and corporate-backed venture capital fund focused on healthcare startups
|
|
| Locked | Locked | Locked |
APIs, injectable excipients, and bioprocessing solutions are manufactured.
|
|
| Locked | Locked | Locked |
Formulations, warehousing, and logistics services for pharmaceuticals are provided.
|
|
| Locked | Locked | Locked |
Pharmaceutical excipients and food ingredients are developed and manufactured.
|
|
| Locked | Locked | Locked |
Developer and manufacturer of excipients for oral solid dosage forms and dry powder inhalations
|
Detailed competitors of SPI Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Spi Pharma
Complete news archive for SPI Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SPI Pharma
SPI Pharma was founded in 2000.
SPI Pharma is headquartered in Wilmington, United States. It is registered at Wilmington, Delaware, United States.
As of Apr 05, 2024, the latest employee count at SPI Pharma is 22.
Annual revenue of SPI Pharma is $1.11M as on Mar 31, 2022.
SPI Pharma was founded in 2000 and is based in Wilmington, United States. Operations center on the pharmaceutical sector, where excipient products and formulation services are provided. Active ingredients for antacids, calcium powders, and functional excipients are developed, alongside drug delivery systems, taste-masked actives, and vaccine adjuvants. Applications encompass orally disintegrating technology and taste-masking processes.
SPI Pharma's top competitors include Colorcon, DFE Pharma and Crest Cellulose.
SPI Pharma offers Pharmaburst 500, Mannogem Mannitol, Pharmasperse, and UltraBurst.